Ginkgo Bioworks Holdings Inc vs YieldMax MSTR Option Income Strategy ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $591.19M), while YieldMax MSTR Option Income Strategy ETF trades at $13.22. The key difference: Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| DNA | MSTY | |
|---|---|---|
Market Cap | $591.19M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $16.14 | $114.30 |
52-Week Low | $5.48 | $11.55 |
Enterprise Value | $628.43M | — |
Trailing returns across standard periods
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →